We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNS icon
2176
Varonis Systems
VRNS
$5B
$137K ﹤0.01%
2,383
-12,101
-84% -$630K
AWI icon
2177
Armstrong World Industries
AWI
$7.84B
$136K ﹤0.01%
1,269
+196
+18% +$20.2K
ICHR icon
2178
Ichor Holdings
ICHR
$2.56B
$136K ﹤0.01%
2,534
-944
-27% -$52K
MSEX icon
2179
Middlesex Water
MSEX
$1.1B
$136K ﹤0.01%
1,671
+246
+17% +$20.4K
SYRS
2180
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$136K ﹤0.01%
2,505
-945
-27% -$55.9K
SWAV
2181
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$136K ﹤0.01%
715
-2,116
-75% -$346K
DRNA
2182
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$136K ﹤0.01%
3,652
+238
+7% +$7.29K
MFNC
2183
DELISTED
Mackinac Financial Corporation
MFNC
$136K ﹤0.01%
6,868
+4,095
+148% +$83.2K
BY icon
2184
Byline Bancorp
BY
$1.76B
$135K ﹤0.01%
5,998
+4,091
+215% +$91.6K
CLOV icon
2185
Clover Health Investments
CLOV
$2.51B
$135K ﹤0.01%
10,119
-77
-0.8% -$756
MGRC icon
2186
McGrath RentCorp
MGRC
$2.92B
$135K ﹤0.01%
1,653
-197
-11% -$16.3K
SITM icon
2187
SiTime
SITM
$21.8B
$135K ﹤0.01%
1,066
+379
+55% +$38.7K
UEC icon
2188
Uranium Energy
UEC
$5.57B
$135K ﹤0.01%
50,557
-52,076
-51% -$157K
CPE
2189
DELISTED
Callon Petroleum Company
CPE
$135K ﹤0.01%
2,333
-6,063
-72% -$255K
PROS
2190
DELISTED
ProSight Global, Inc.
PROS
$135K ﹤0.01%
10,586
+3,198
+43% +$40.7K
LGND icon
2191
Ligand Pharmaceuticals
LGND
$6.36B
$134K ﹤0.01%
1,637
-160
-9% -$13.3K
RLAY icon
2192
Relay Therapeutics
RLAY
$4.33B
$134K ﹤0.01%
3,637
-20
-0.5% -$659
RVMD icon
2193
Revolution Medicines
RVMD
$44B
$134K ﹤0.01%
4,219
+2,176
+107% +$75.9K
SPOT icon
2194
Spotify
SPOT
$100B
$134K ﹤0.01%
485
-16,676
-97% -$4.23M
PRTY
2195
DELISTED
Party City Holdco Inc.
PRTY
$134K ﹤0.01%
14,347
-1,694
-11% -$13.8K
CWEN.A
2196
DELISTED
Clearway Energy Class A
CWEN.A
$133K ﹤0.01%
5,280
-7,446
-59% -$191K
NTCT icon
2197
NETSCOUT
NTCT
$2.79B
$133K ﹤0.01%
4,644
-3,691
-44% -$105K
REMX icon
2198
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.26B
$133K ﹤0.01%
1,565
+1,294
+477% +$105K
XPEL icon
2199
XPEL
XPEL
$1.38B
$133K ﹤0.01%
1,593
+51
+3% +$3.76K
ITCI
2200
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$133K ﹤0.01%
3,253
-4,988
-61% -$184K
86 87
88
89 90

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.